Zensho Ito
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Gut microbiota and health 3
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Shigeo Koido (28 shared papers)Mikio Kajihara (16 shared papers)Kazuki Takakura (13 shared papers)Toshifumi� Ohkusa (18 shared papers)Takeyuki Misawa (9 shared papers)Toshifumi Ohkusa (7 shared papers)Tomoya Kanai (7 shared papers)Masayuki Saruta (12 shared papers)
- Journals
- PLoS ONE (3 papers)BMC Gastroenterology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)The American Journal of Gastroenterology (2 papers)Drug Discoveries & Therapeutics (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Zensho Ito
28 papers receiving 407 citations
Peers
Comparison fields: 5 of 60
- Oncology 160
- Immunology 127
- Molecular Biology 161
- Hepatology 15
- Cancer Research 20
Countries citing papers authored by Zensho Ito
This map shows the geographic impact of Zensho Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zensho Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zensho Ito more than expected).
Fields of papers citing papers by Zensho Ito
This network shows the impact of papers produced by Zensho Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zensho Ito. The network helps show where Zensho Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Zensho Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 61 | |
| 2 | 2019 | 42 | |
| 3 | 2019 | 38 | |
| 4 | 2016 | 32 | |
| 5 | 2021 | 27 | |
| 6 | Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer. | 2015 | 27 |
| 7 | 2017 | 26 | |
| 8 | 2015 | 24 | |
| 9 | 2015 | 22 | |
| 10 | 2022 | 18 | |
| 11 | 2024 | 14 | |
| 12 | 2018 | 12 | |
| 13 | 2019 | 10 | |
| 14 | Dendritic-tumor fusion cells in cancer immunotherapy. | 2015 | 10 |
| 15 | 2017 | 9 | |
| 16 | 2014 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2016 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2022 | 4 |
About Zensho Ito
Zensho Ito is a scholar working on Oncology, Molecular Biology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 413 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Inflammatory Bowel Disease (4 papers), Gut microbiota and health (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Fatty Acid Research and Health (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (160 citations), Immunology (127 citations), Molecular Biology (161 citations), Hepatology (15 citations) and Cancer Research (20 citations). Zensho Ito has collaborated with scholars based in Japan and United States. Frequent co-authors include Shigeo Koido, Mikio Kajihara, Kazuki Takakura, Toshifumi� Ohkusa, Takeyuki Misawa, Toshifumi Ohkusa, Tomoya Kanai, Masayuki Saruta, Masato Okamoto and Kan Uchiyama. Their work appears in journals such as PLoS ONE, BMC Gastroenterology, Journal for ImmunoTherapy of Cancer, The American Journal of Gastroenterology and Drug Discoveries & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.